CelSci CVM Q4 2024 Earnings Beat Revenue NA EPS 270 Domo DOMO Gained 204 Can It Break 368 20260515 Yatsen YSG Q4 2025 Earnings Revenue NA Matching Views China Spy Case in Norway Raises Questions Over European Arctic Security Posture UK Economy Understanding GDP Growth and Current Trends US Productivity Growth Slows in Q4 as Unit Labor Costs Accelerate AST SpaceMobile and Rocket Lab A Comparative Look at Two Space Stocks for 2026 US SEC Proposes Allowing Public Companies to Opt Out of Quarterly Earnings Reports New York Yankees Send Concise Message on Aaron Judge as Concerns Mount US Job Market Weakens in October and November Federal Data Shows UGI Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher Embecta Corp EMBC Q1 2026 Earnings EPS Misses Expectations as Revenue Data Remains Unavailable KVYO Q1 2026 Earnings EPS Beat Amidst Modest Stock Decline HTFC Q1 2026 Earnings Slight EPS Miss Amid Stable Portfolio Performance Insight Molecular Diagnostics Inc IMDX Q1 2026 Earnings EPS Surprises to the Upside During PreRevenue Phase CheckCap Ltd MBAI Q3 2023 Earnings EPS Misses Estimates as PreRevenue Company Continues RD Efforts Mountain Lake Acquisition Corp MLAC Holds Steady Near 1060 Amid Tight Trading Range Grupo Aeromexico AERO Rises 4 as Airline Sector Optimism Drives Momentum Dutch Bros Inc BROS Gains 181 as Stock Holds Above Key Support Level East West Bancorp EWBC Edges Lower as Shares Test Key Support Levels TSS Inc TSSI Gains Momentum Approaching Key Resistance at 1261 UK Police Chiefs Call for Blocking Unsafe Platforms for Under16s Raising Regulatory Pressure on Tech Firms IDXX Q1 2026 Earnings Modest EPS Beat Amid Flat Revenue Backdrop IMUX Q1 2026 Earnings Wider Loss Than Expected but Stock Gains on Pipeline Momentum Michael Burrys Scion Asset Management Discloses New Stake in Alibaba BABA EOG Q1 2026 Earnings Strong EPS Beat Amid Modest Stock Decline Retail Investors Gain Direct Access to SpaceX IPO Through Major Brokerage Platforms ATO Q1 2026 Earnings EPS Beats Estimates Amidst Operational Discipline Tarsus Pharmaceuticals TARS Faces Resistance at 63 Pulls Back to 60 Support Zone